首页|驱动蛋白家族成员15(KIF15)对肝细胞癌增殖能力的影响及其作用机制

驱动蛋白家族成员15(KIF15)对肝细胞癌增殖能力的影响及其作用机制

扫码查看
目的 探究驱动蛋白家族成员15(KIF15)对肝细胞癌(HCC)增殖能力的影响及其作用机制.方法 通过分析TCGA和GEPIA数据集确定KIF15在HCC中的表达情况以及对肿瘤分期、生存的影响.采用qRT-PCR和Western Blot检测体外培养的人源HCC细胞系(HepG2、Hep3B、MHCC-97H和LM3)与人正常肝细胞系L02细胞的KIF15表达水平,并选择Hep3B和HepG2进行后续研究.通过对Hep3B慢病毒转染sh-NC/sh-KIF15和对HepG2慢病毒转染LV-vector/LV-KIF15进行CCK-8、平板克隆和EdU染色实验评估细胞的活力和增殖能力.GSEA分析KIF15与HCC相关的作用信号通路并通过Western Blot进行检测.计量资料两组间比较采用成组t检验;多组间比较采用单因素方差分析,进一步两两比较采用LSD-t检验.结果 TCGA和GEPIA数据集分析结果显示KIF15在HCC患者癌组织中的表达明显高于正常组织,并且KIF15与HCC分期成正比,KIF15高表达的HCC患者的生存更差.与sh-NC-Hep3B相比,sh3-Hep3B的KIF15 mRNA水平和蛋白水平均下降(P值均<0.05);与sh-NC-Hep3B相比,sh3-Hep3B的细胞活力、克隆形成数和EdU阳性率均显著降低(P值均<0.05).与vector-HepG2相比,LV-KIF15-HepG2的KIF15 mRNA水平和蛋白水平均升高(P值均<0.05);与vector-HepG2相比,LV-KIF15-HepG2的细胞活力、克隆形成数和EdU阳性率均提高(P值均<0.05).皮下瘤实验结果显示:与sh-NC-Hep3B相比,sh3-Hep3B的瘤体积和瘤重量降低;Ki67的组化评分降低,而TUNEL的组化评分提高(P值均<0.05).GSEA分析显示在HCC中PI3K/AKT/mTOR通路与KIF15呈正相关(NES=1.59,P<0.001),Western Blot检测发现LY294002能够抑制LV-KIF15-HepG2中上调的PI3K/AKT/mTOR通路,与LV-KIF15-HepG2相比,LY294002+LV-KIF15-HepG2的细胞活力、克隆形成数和EdU阳性率降低(P值均<0.05).结论 KIF15通过上调PI3K/AKT/mTOR信号通路增强HCC的活力和增殖能力.
Effect of kinesin family member 15 on the proliferation of hepatocellular carcinoma cells and its mechanism of action
Objective To investigate the effect of kinesin family member 15(KIF15)on the proliferation of hepatocellular carcinoma(HCC)cells and its mechanism of action.Methods TCGA and GEPIA datasets were analyzed to determine the expression of KIF15 in HCC and its effect on tumor stage and survival.Quantitative real-time PCR and Western blot were used to measure the expression level of KIF15 in human-derived HCC cell lines(HepG2,Hep3B,MHCC-97H,and LM3)and human normal liver cell line L02 cultured in vitro,and Hep3B and HepG2 were selected for subsequent studies.CCK-8 assay,plate colony formation assay,and EdU staining were performed for Hep3B cells transfected with shRNA-NC or shRNA-KIF15 and HepG2 cells transfected with LV-vector or LV-KIF15 to evaluate the viability and proliferative capacity of these cells.GSEA was used to analyze the potential signaling pathways associated with KIF15 in HCC,and Western blot was used for detection.The independent-samples t test was used for comparison of continuous data between two groups;a one-way analysis of variance was used for comparison between multiple groups,and the least significant difference t-test was used for further comparison between two groups.Results The analysis of TCGA and GEPIA datasets showed that in HCC patients,the expression of KIF15 in HCC tissue was significantly higher than that in normal tissue,and the HCC patients with high KIF15 expression tended to have a poorer prognosis.Compared with sh-NC-Hep3B,sh3-Hep3B showed significant reductions in the mRNA and protein levels of KIF15(P<0.05),cell viability,clone formation number,and EdU positive rate(all P<0.05).Compared with vector-HepG2,LV-KIF15-HepG2 showed significant increases in the mRNA and protein levels of KIF15(P<0.05),cell viability,clone formation number,and EdU positive rate(all P<0.05).Subcutaneous tumor assay showed that compared with sh-NC-Hep3B,sh3-Hep3B showed reductions in tumor volume and tumor weight,as well as a significant reduction in the immunohistochemical score of Ki67 and a significant increase in the immunohistochemical score of TUNEL(P<0.05).GSEA analysis showed that the PI3K/AKT/mTOR pathway was positively correlated with KIF15 in HCC(NES=1.59,P<0.001).Western blot showed that LY294002 could inhibit the PI3K/AKT/mTOR pathway upregulated in LV-KIF15-HepG2,and compared with LV-KIF15-HepG2,LY294002+LV-KIF15-HepG2 showed significant reductions in cell viability,clone formation number,and EdU positive rate(all P<0.05).Conclusion KIF15 enhances the viability and proliferative capacity of HCC cells by upregulating the PI3K/AKT/mTOR signaling pathway.

Carcinoma,HepatocellularKinesinSignal TransductionCell Proliferation

仇建南、汪鹏、曹胤、王忠夏、吴俊华、江春平

展开 >

南京大学医学院附属鼓楼医院肝胆外科, 南京 210008

南京大学医学院基础医学部, 南京 210093

癌,肝细胞 驱动蛋白 信号传导 细胞增殖

国家自然科学基金

81972888

2024

临床肝胆病杂志
吉林大学

临床肝胆病杂志

CSTPCD北大核心
影响因子:1.428
ISSN:1001-5256
年,卷(期):2024.40(2)
  • 1
  • 2